| P2093 | author name string | Akira Shimada | |
| | Hitoshi Ichikawa | |
| | Keizo Horibe | |
| | Tohru Kobayashi | |
| | Masahiro Tsuchida | |
| | Hirokazu Arakawa | |
| | Yasuhide Hayashi | |
| | Ryoji Hanada | |
| | Souichi Adachi | |
| | Akio Tawa | |
| | Manabu Sotomatsu | |
| | Myoung-Ja Park | |
| | Norio Shiba | |
| | Tomohiko Taki | |
| | Ichiro Tsukimoto | |
| | Aoi Jo | |
| | Sachiyo Mitani | |
| P2860 | cites work | Cluster analysis and display of genome-wide expression patterns | Q24644463 |
| | A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study | Q24651897 |
| | Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations | Q27824843 |
| | The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13, but not HOXA9 | Q28214336 |
| | Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia | Q28273406 |
| | Biology, risk stratification, and therapy of pediatric acute leukemias: an update | Q34764504 |
| | Prdm16 is a physiologic regulator of hematopoietic stem cells. | Q35029415 |
| | NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights | Q35608150 |
| | The pathophysiology of HOX genes and their role in cancer. | Q36005947 |
| | Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia | Q36174146 |
| | NUP98 fusion in human leukemia: dysregulation of the nuclear pore and homeodomain proteins | Q36232552 |
| | Genetics of myeloid malignancies: pathogenetic and clinical implications | Q36254578 |
| | NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique. | Q36391820 |
| | Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia | Q37172988 |
| | Acquired copy number alterations in adult acute myeloid leukemia genomes | Q37276767 |
| | Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications | Q37827283 |
| | Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group | Q40148405 |
| | Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group | Q44158544 |
| | KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group | Q46807536 |
| | Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients. | Q51655820 |
| | A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. | Q52543603 |
| | RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study Group. | Q53384430 |
| | DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia. | Q53403193 |
| | Age-associated difference in gene expression of paediatric acute myelomonocytic lineage leukaemia (FAB M4 and M5 subtypes) and its correlation with prognosis. | Q54500618 |
| | A cryptic t(5;11)(q35;p15.5) in 2 children with acute myeloid leukemia with apparently normal karyotypes, identified by a multiplex fluorescence in situ hybridization telomere assay | Q56263809 |
| | Frequency of NUP98-NSD1 fusion transcript in childhood acute myeloid leukaemia | Q61852050 |
| | Cryptic t(5;11)(q35;p15.5) in adult de novo acute myelocytic leukemia with normal karyotype | Q73847829 |
| | Cryptic translocation t(5;11)(q35;p15.5) with involvement of the NSD1 and NUP98 genes without 5q deletion in childhood acute myeloid leukemia | Q78294890 |
| | Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia | Q80310198 |
| | Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult refractory anemia with an excess of blasts | Q80594737 |
| | Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: a study of the Japanese childhood AML Cooperative Study Group | Q80974291 |
| | NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern | Q84668776 |
| | Prospective study of a therapeutic regimen with all‐trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative study | Q84797439 |
| | High frequencies of simultaneous FLT3-ITD, WT1 and KIT mutations in hematological malignancies with NUP98-fusion genes | Q85068917 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 683-693 | |
| P577 | publication date | 2013-04-30 | |
| P1433 | published in | Genes, Chromosomes and Cancer | Q5532697 |
| P1476 | title | NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia | |
| P478 | volume | 52 | |